ATTR Progression: A Word We Need to Talk About

There is a word that rarely shows up when people talk about transthyretin (ATTR) amyloidosis.

Terminal.

When you search for information about this disease, most of what you find is hopeful - and I understand why. You see articles about awareness. About early diagnosis. About medications that slow the disease. About breakthroughs and research and what might be coming next. And all of that matters. It really does. We are living in a time when treatments exist that didn’t exist for the people who came before us.

What does progression mean for ATTR amyloidosis?

My dad didn’t have the options that I have today.

So yes, the progress matters. I’m grateful for it.

But there is another truth that often gets left out of the conversation, and I think we do ourselves a disservice when we pretend it isn’t there.

ATTR is still a terminal disease.

Treatment can slow it down. Sometimes it slows it down a lot. But slow is not the same thing as stop. And stop is not the same thing as cure.

Those are very different things.

Symptoms of progression

Sometimes when people talk about ATTR now, it almost sounds as if the problem has been solved. As if the medications have changed everything. And in many ways they have changed things for the better - but they haven’t changed the reality that the disease is still progressing inside our bodies.

Progression doesn’t usually happen in big dramatic moments. It’s quieter than that. It shows up in small ways at first.

Your fingers don’t quite do what they used to. Buttons take a little more time. Your hands don’t cooperate the way they did a year ago. Walking feels different. Your legs get tired sooner than they used to. Stairs feel steeper. Distances feel longer.

None of it happens all at once.

You adjust. You adapt. You keep going. Most of the time you don’t even talk about it.

But the changes keep happening.

Talking about your health with loved ones

And that’s the part of ATTR that is hardest to explain to people who aren’t living with it. From the outside, slowing progression can look like stability. It can look like success. It can look like everything is under control.

From the inside, you know things are still slipping away.

Not all at once. Not dramatically. But slowly enough that you feel it.

Living with ATTR changes the way you think about time. You start to notice things other people don’t notice. You become aware of the abilities you still have, because you understand they may not always be there. There’s gratitude in that, but there’s also grief. And sometimes those two things exist in the same moment.

I think we need to make more space for that truth in these conversations.

Not to take away hope - but to be honest.

Because hope and honesty can exist together.

The truth is, this disease is still terminal. And we shouldn’t forget that. Not because we want to dwell on it, but because remembering it should light a fire under all of us.

It should push research forward faster.
It should push for better treatments.
And ultimately, it should push toward a cure.

Slowing the disease is important. It buys time. And time matters more to someone living with a progressive illness than most people can understand.

But slowing it down cannot be the finish line.

The finish line is stopping it completely.

The finish line is a cure.

Until we get there, I think it’s important that we keep telling the whole story of ATTR - not just the hopeful parts, but the hard ones too. Because the truth about this disease is exactly what should drive the next breakthrough.

And the people living with ATTR deserve nothing less.